0001144204-12-032294.txt : 20120529 0001144204-12-032294.hdr.sgml : 20120528 20120529172506 ACCESSION NUMBER: 0001144204-12-032294 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20120529 DATE AS OF CHANGE: 20120529 EFFECTIVENESS DATE: 20120529 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Advaxis, Inc. CENTRAL INDEX KEY: 0001100397 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 841521955 STATE OF INCORPORATION: DE FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-178942 FILM NUMBER: 12875104 BUSINESS ADDRESS: STREET 1: TECHNOLOGY CENTRE OF NEW JERSEY STREET 2: 675 ROUTE 1 CITY: NORTH BRUNSWICK STATE: NJ ZIP: 08902 BUSINESS PHONE: 732 545 1590 MAIL ADDRESS: STREET 1: TECHNOLOGY CENTRE OF NEW JERSEY STREET 2: 675 ROUTE 1 CITY: NORTH BRUNSWICK STATE: NJ ZIP: 08902 FORMER COMPANY: FORMER CONFORMED NAME: GREAT EXPECTATIONS & ASSOCIATES INC DATE OF NAME CHANGE: 19991203 D 1 primary_doc.xml X0705 D LIVE 0001100397 Advaxis, Inc. 305 COLLEGE ROAD EAST PRINCETON NJ NEW JERSEY 08540 609-452-9813 DELAWARE Great Expectations and Associates, Inc. GREAT EXPECTATIONS & ASSOCIATES INC Corporation true Thomas Moore 305 COLLEGE ROAD EAST PRINCETON NJ NEW JERSEY 08540 Executive Officer Director James Patton 305 COLLEGE ROAD EAST PRINCETON NJ NEW JERSEY 08540 Director Roni A. Appel 305 COLLEGE ROAD EAST PRINCETON NJ NEW JERSEY 08540 Director Thomas L. McKearn 305 COLLEGE ROAD EAST PRINCETON NJ NEW JERSEY 08540 Director Richard Berman 305 COLLEGE ROAD EAST PRINCETON NJ NEW JERSEY 08540 Director John Rothman 305 COLLEGE ROAD EAST PRINCETON NJ NEW JERSEY 08540 Executive Officer Mark J. Rosenblum 305 COLLEGE ROAD EAST PRINCETON NJ NEW JERSEY 08540 Executive Officer Biotechnology Decline to Disclose 06 false 2012-05-14 false true true true false 0 Indefinite 4473673 Indefinite Advaxis did not receive any cash proceeds in the exchanges. However, certain holders of $4,473,673 of Advaxis' convertible promissory notes surrendered such notes and related warrants in exchange for shares and new warrants. false 29 0 0 0 false Advaxis, Inc. /s/ Mark J. Rosenblum Mark J. Rosenblum Chief Financial Officer, Senior Vice President and Secretary 2012-05-29